Brief: Ryvu Therapeutics Signs Placement Deal And Starts ABB Process
13/07/2020 16:27
July 13 (Reuters) - Ryvu Therapeutics SA RVU.WA :
* SIGNS PLACEMENT DEAL WITH UBS EUROPE AND IPOPEMA
SECURITIES
* STARTS ABB PROCESS UNDER PRIVATE SUBSCRIPTION OF UP TO 2.4
MILLION I SERIES SHARES
Source text for Eikon: ID:nEM6hsHMKa
Further company coverage: RVU.WA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Ryvu Therapeutics SA
See all newsBrief: Ryvu Therapeutics Q1 Net Loss 12.6 Million Zlotys
Brief: Ryvu Therapeutics Updates Romacyclib Development Strategy
Brief: Ryvu Therapeutics FY Net Loss At 101.2 Mln Zlotys
Brief: Ryvu Therapeutics Extends Research Collaboration And Exclusive License Agreement With BioNTech Until Nov 29, 2028
Brief: Ryvu Therapeutics Signs Grant Agreement With Poland's NCBR For PERO Project